|Articles|October 26, 2016
SCRS Announces CLEAR Contract Clauses
SCRS has announced the release of the Common Language Evaluation and Reconciliation (CLEAR) contract clauses for clinical research site contracts in North America.
Advertisement
SCRS has announced the release of the Common Language Evaluation and Reconciliation (CLEAR) contract clauses for clinical research site contracts in North America. The purpose of CLEAR is to streamline contract negotiations, accelerate site initiations, increase recruitment timeliness and thus reduce study start-up costs.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Selective Safety Data and Visit Reduction, Protocol Design Execution Gaps, and China Trial Security Investigation
2
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
3
ACT Brief: Tavneos Trial Integrity Issues, Selective Safety Data Regulatory Pathways, and FDA PreCheck Program Launch
4
ACT Brief: Real-Time Trial Infrastructure Gaps, Built-In Data Security, and AI-Enabled CDMO Value
5